More than 2 million people in the United States have profound hearing loss. Most profoundly hearing-impaired people do not benefit from traditional hearing aids, but cochlear implants may provide them with an alternative to deafness.
The Ruch Cochlear Implant program uses state-of-the-art technology to treat severe-to-profoundly hearing-impaired patients.
The Rush Cochlear Implant Program is a joint venture of the Department of Otolaryngology and the Section of Communicative Disorders and Sciences. The team includes medical specialists and audiologists, all of whom hold master's or doctoral degrees and certificates of competence from the American Speech-Language-Hearing Association.